TRCT
XGN icon

Tower Research Capital (TRC)’s Exagen XGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Buy
+2,968
New +$11.2K ﹤0.01% 3839
2026
Q1 		– Sell
-3,528
Closed -$21.4K – 5623
2025
Q4 		$21.4K Buy
+3,528
New +$32.1K ﹤0.01% 3050
2025
Q2 		– Sell
-62
Closed -$223 – 5610
2025
Q1 		$223 Sell
62
-1,265
-95% -$4.78K ﹤0.01% 4967
2024
Q4 		$5.44K Buy
1,327
+15
+1% +$54 ﹤0.01% 4287
2024
Q3 		$4.05K Sell
1,312
-4,991
-79% -$12.9K ﹤0.01% 4696
2024
Q2 		$11.5K Buy
6,303
+2,297
+57% +$3.89K ﹤0.01% 4080
2024
Q1 		$6.37K Sell
4,006
-946
-19% -$1.84K ﹤0.01% 4386
2023
Q4 		$9.85K Buy
+4,952
New +$8.56K ﹤0.01% 4337
2023
Q3 		– Sell
-65
Closed -$188 – 6284
2023
Q2 		$188 Buy
+65
New +$185 ﹤0.01% 5753
2023
Q1 		– Sell
-1,476
Closed -$4K – 6337
2022
Q4 		$4K Buy
1,476
+1,441
+4,117% +$3.7K ﹤0.01% 5082
2022
Q3 		$0 Buy
+35
New +$195 ﹤0.01% 6548
2022
Q2 		– Sell
-1,929
Closed -$15K – 6577
2022
Q1 		$15K Buy
1,929
+962
+99% +$8.29K ﹤0.01% 3844
2021
Q4 		$11K Buy
967
+154
+19% +$1.8K ﹤0.01% 4469
2021
Q3 		$11K Buy
813
+11
+1% +$146 ﹤0.01% 4266
2021
Q2 		$12K Buy
802
+163
+26% +$2.5K ﹤0.01% 4295
2021
Q1 		$11K Sell
639
-3,224
-83% -$57.4K ﹤0.01% 4324
2020
Q4 		$51K Sell
3,863
-2,501
-39% -$35.3K ﹤0.01% 3110
2020
Q3 		$69K Buy
6,364
+5,566
+697% +$71.7K ﹤0.01% 3397
2020
Q2 		$10K Buy
+798
New +$10.8K ﹤0.01% 4023
2020
Q1 		– Sell
-424
Closed -$11K – 4006
2019
Q4 		$11K Buy
+424
New +$7.54K ﹤0.01% 2298

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Tower Research Capital (TRC)'s XGN Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Exagen (XGN) in Q2 2026: 2,968 shares worth $13.8K. The stake represents ﹤0.01% of the portfolio and ranks #3839 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in XGN as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in XGN in Q4 2019 and has held it in 20 quarters since. The position peaked at $69K in Q3 2020. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Tower Research Capital (TRC) held 2,968 shares of Exagen worth $13.8K as of Q2 2026.
  • Exagen was a new Tower Research Capital (TRC) position in Q2 2026.
  • Exagen made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3839 holding.
  • Tower Research Capital (TRC) first reported a position in Exagen in Q4 2019 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Exagen position peaked at $69K in Q3 2020.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.